Insmed, Inc. (INSM)
137.09
-2.35
(-1.69%)
USD |
NASDAQ |
May 06, 16:00
128.50
-8.59
(-6.27%)
Pre-Market: 08:20
Insmed Free Cash Flow : -997.58M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals, Inc. | -275.41M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| PTC Therapeutics, Inc. | 411.18M |
| United Therapeutics Corp. | 1.011B |
| Amicus Therapeutics, Inc. | 29.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -247.60M |
| Cash from Investing (Quarterly) | 389.41M |
| Cash from Financing (Quarterly) | 33.86M |
| Free Cash Flow Per Share (Quarterly) | -1.377 |
| Free Cash Flow to Equity (Quarterly) | -305.09M |
| Free Cash Flow to Firm (Quarterly) | -273.49M |
| Free Cash Flow Yield | -3.66% |